Skip to main content

Amundi

Position in CRNX — Crinetics Pharmaceuticals, Inc.

CIK 1330387 Paris, I0

Position in CRNX

as of Jun 30, 2026 · filed Aug 11, 2026
Position Value
$351,486
-$121,908 QoQ
Shares Held
9,393
-27.9% QoQ
Ownership
0.009%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#164
of 264 holders
Holding Since
Sep 2022
12 quarters on record
Voting authority Sole 100% Shared 0% None 0%

Common Shares in CRNX Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Jun 30, 2026

Amundi holds $2,427,056,148 across 70 Biotechnology names. CRNX ranks #46 (0.0% of the industry book) .

# Ticker Company Shares Value (USD) Open

All Filings in CRNX

Export CSV
12 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $351,486 9,393
2026-03-31 $473,394 13,034
2025-12-31 $261,704 5,622
2025-03-31 $1,911 57
2024-12-31 $2,658 52
2024-03-31 $156,907 3,352
2023-12-31 $119,264 3,352
2023-09-30 $54,126 1,820
2023-06-30 $32,796 1,820
2023-03-31 $52,917 3,295
2022-12-31 $60,298 3,295
2022-09-30 $64,713 3,295